BiotechTube
Trina Bioreactives

Trina Bioreactives

Lausanne, Switzerland· Est.
trinabio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

Trina Bioreactives operates as a specialized sourcing and manufacturing partner for the global IVD industry, providing essential biological raw materials from its base in Lausanne, Switzerland. The company's core business revolves around supplying characterized human serum, plasma, disease-state specimens, antigens, and antibodies, which are fundamental for developing and calibrating diagnostic assays. With an ISO 13485:2016 certified quality system and a claimed production volume of 1.3 million liters of plasma, it serves customers in over 40 countries. Its model is built on a vast sustainable network of manufacturing partners and a proprietary biorepository, catering to custom requirements for top-tier diagnostics firms.

Antibodies

Technology Platform

Integrated operational and quality system for the ethical sourcing, processing, characterization, and distribution of biological raw materials (human biospecimens, antigens, antibodies) for the IVD industry, leveraging a decentralized manufacturing partner network.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

Growth is driven by the expanding global IVD market and the increasing complexity of diagnostics, which boosts demand for well-characterized disease-state specimens and custom panels.
Adjacent expansion into cell culture products for biomanufacturing presents an additional revenue stream.
The company's Swiss quality reputation and ISO certification are key assets in securing contracts with top-tier, regulated clients.

Risk Factors

The business is highly dependent on a complex network of third-party suppliers and collectors, introducing quality control and supply continuity risks.
The industry faces intense regulatory scrutiny over human-derived materials, where any compliance failure could be catastrophic.
Competition and potential margin pressure from both other suppliers and in-house client sourcing initiatives pose ongoing challenges.

Competitive Landscape

Trina competes in the niche market of IVD raw material suppliers against other specialized firms like SeraCare Life Sciences (part of LGC), BioIVT, and regional biospecimen providers. Its key differentiators are its Swiss regulatory positioning, extensive catalog of characterized disease-state samples, and a partnership model emphasizing flexibility. Large IVD companies themselves represent potential competition if they choose to internalize sourcing.

More companies in Diagnostics & Precision Medicine →More companies in Switzerland →